The reporter indicated that the surgeon implanted a 12.6 mm vticm5_12.6, -4.5/1.5/86 diopter, implantable collamer lens in the patient's left eye (os) on (b)(6) 2017.The next day, signs of toxic anterior segment syndrome, include tearing, pain, blurry vision, eyelid edema, hyperemia, corneal edema, fixed pupil and fibrin clot in the anterior chamber was noticed.Therapy was started with oral prednisolone (60 mg/day) and acetazolamide 250 mm (1+1+1), tropical prednisolone 1 drop per hour, trapicamide, ofloxacine, and bromofenac.The following day, the patient experience less pain, intense hyperemia, less eyelid edema but a very cloudy whitish cornea.Corneal periphery was partially pared and a blood clot was seen in the inferior a.C.An anterior chamber washing was performed as well as the temporal incision witch being sutured with 2 10/00 nylon stiches and intravitreous injection of vancomicine 1mg/0.1 ml and ceftazidime 1.0 mg/0.1 ml.According to the surgeon, the cornea is clearing up and would need to make another surgery to remove the membrane.
|
Device history record (dhr) review: based on the results of the investigation, all released devices from the associated work order(s), including the suspected device, have been manufactured within established process parameters; and there is no indication that the manufacturing and processing of the device contributed to the complaint issue.(b)(4).
|